Page last updated: 2024-08-23

bromocriptine and Obesity

bromocriptine has been researched along with Obesity in 48 studies

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19908 (16.67)18.7374
1990's13 (27.08)18.2507
2000's15 (31.25)29.6817
2010's8 (16.67)24.3611
2020's4 (8.33)2.80

Authors

AuthorsStudies
Auriemma, RS; Colao, A; Graziadio, C; Pirchio, R; Pivonello, R1
Aslanoglou, D; Benner, V; Farino, ZJ; Freyberg, Z; Lopez-Valencia, M; McCarthy, MJ; Osborn, O; Wei, H; Zapata, RC1
Bloomgarden, Z1
Barra, C; Conde, SV; Costa, A; Gasparini, P; Marques, D; Matafome, P; Melo, BF; Rodrigues, T; Rosendo-Silva, D; Sacramento, JF; Seiça, R; Tavares, G1
Boaventura, G; Casimiro-Lopes, G; Lisboa, PC; Moura, EG; Oliveira, E; Pazos-Moura, CC1
Carvalho, JC; Conceição, EP; de Oliveira, E; Lima, NS; Lisboa, PC; Moura, EG; Nogueira-Neto, JF; Peixoto-Silva, N1
Carvalho, JC; de Oliveira, E; Lisboa, PC; Moura, EG; Nobre, JL; Peixoto-Silva, N; Pinheiro, CR; Quitete, FT; Santos-Silva, AP1
Frölich, M; Kok, P; Meinders, AE; Pijl, H; Roelfsema, F; van Pelt, J3
Aja, S; Cheskin, LJ; Contoreggi, C; Davis, LM; Hope, B; McCullough, K; Michaelides, M; Moran, TH; Pei, Z; Thanos, PK; Volkow, ND; Wang, GJ; Watkins, PA1
Bonomo, IT; de Moura, EG; de Oliveira, E; Lisboa, PC; Nogueira-Neto, JF; Passos, MC; Reis, AM; Trevenzoli, IH1
Bonomo, IT; de Oliveira, E; Lima, NS; Lisboa, PC; Moura, EG; Passos, MC; Pires, L; Reis, AM1
Barbosa, FR; Domingues, RC; dos Santos Silva, CM; Fontes, R; Gadelha, MR; Lima, GA; Warszawski, L1
Anderson, BJ; Bray, GA; Cho, J; Kim, R; Michaelides, M; Primeaux, SD; Robinson, JK; Thanos, PK; Volkow, ND; Wang, GJ1
Bray, G; Cho, J; Kim, R; Michaelides, M; Primeaux, S; Thanos, PK; Volkow, ND; Wang, GJ1
de Leeuw van Weenen, JE; Parlevliet, ET; Pijl, H; Romijn, JA; Schröder-van der Elst, JP; van den Berg, SA; Willems van Dijk, K1
Amini, M; Aminorroaya, A; Haghighi, S; Janghorbani, M; Ramezani, M1
Cheskin, LJ; Contoreggi, C; Davis, LM; McCullough, K; Moran, TH; Pei, Z; Trush, MA; Watkins, PA1
Frölich, M; Kok, P; Meinders, AE; Pijl, H; Roelfsema, F; Stokkel, MP; van Pelt, J1
Cerman, J; Golda, V; Petr, R; Suba, P; Votruba, M1
Cincotta, AH; Meier, AH2
Roush, W1
Cvak, L; Golda, V1
Barberis, A; Camanni, F; Ciccarelli, E; Ghigo, E; Grottoli, S; Maccario, M; Oleandri, SE; Procopio, M1
Cincotta, AH; Scislowski, PW; Tozzo, E1
Chen, YD; Cincotta, AH; Jones, CN; Kamath, V; Reaven, GM; Varasteh, BB; Yip, JC1
Cincotta, AH; Luo, S; Meier, AH1
Cincotta, AH; Liang, Y; Luo, S1
Cincotta, AH; Phaneuf, S; Prevelige, R; Scislowski, PW; Tozzo, E; Zhang, Y1
Cincotta, AH; Kraszewski, KZ1
Cincotta, AH; Luo, J; Luo, S1
Iwamoto, Y; Kawahara, R; Wasada, T1
Reaven, GM1
Cincotta, AH; DeFronzo, RA; Iozzo, P; Kumar, V; Lancaster, JL; Mahankali, A; Matsuda, M; Miyazaki, Y; Ohashi, S; Pijl, H; Pipek, R1
Barzaghi, ME; Beck-Peccoz, P; Bortolani, E; Corti, D; Forloni, F; Giovilli, M; Pecis, C; Preziosi, A1
Casanueva, F; Dieguez, C; Doknic, M; Medic-Stojanoska, M; Pekic, S; Popovic, V; Zarkovic, M1
Craig, A; Harrower, AD; Nairn, IM; Strong, JA; Walton, HJ; Yap, PL1
Franks, S; Jacobs, HS; Jequier, AM; Murray, MA; Nabarro, JD; Steele, SJ1
Manusharova, RA1
Cincotta, AH; Lovell, WC; Meier, AH1
Cincotta, AH; Meier, AH; Schiller, BC1
Tiwary, CM1
Burema, J; Deurenberg, P; Rokebrand, P; Rookus, MA1
Vaitukaitis, JL1
Adams, J; Franks, S; Mason, H; Polson, D1
Blom, HL; Larsson, LO1

Reviews

2 review(s) available for bromocriptine and Obesity

ArticleYear
Metabolic effects of prolactin.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Bromocriptine; Cabergoline; Dopamine; Dopamine Agonists; Glucose; Humans; Hyperprolactinemia; Lipids; Male; Metabolic Syndrome; Obesity; Prolactin; Receptors, Dopamine; Receptors, Prolactin; Testosterone; Weight Gain

2022
Ovulatory disorders in women with polycystic ovary syndrome.
    Clinics in obstetrics and gynaecology, 1985, Volume: 12, Issue:3

    Topics: Androgens; Anovulation; Bromocriptine; Chorionic Gonadotropin; Clomiphene; Diagnosis, Differential; Estrogens; Female; Follicle Stimulating Hormone; Glucocorticoids; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Hirsutism; Humans; Hyperprolactinemia; Infertility, Female; Menotropins; Menstruation Disturbances; Obesity; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Ultrasonography

1985

Trials

10 trial(s) available for bromocriptine and Obesity

ArticleYear
Short-term treatment with bromocriptine improves impaired circadian growth hormone secretion in obese premenopausal women.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:9

    Topics: Adult; Bromocriptine; Chronobiology Disorders; Circadian Rhythm; Cross-Over Studies; Dopamine Agonists; Female; Human Growth Hormone; Humans; Insulin; Leptin; Middle Aged; Obesity; Placebos; Premenopause; Time Factors

2008
Does bromocriptine improve glycemic control of obese type-2 diabetics?
    Hormone research, 2004, Volume: 62, Issue:2

    Topics: Adult; Aged; Blood Glucose; Body Mass Index; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Double-Blind Method; Drug Synergism; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Placebos

2004
Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
    American journal of physiology. Endocrinology and metabolism, 2006, Volume: 291, Issue:5

    Topics: Adult; Blood Glucose; Bromocriptine; Calorimetry, Indirect; Circadian Rhythm; Cross-Over Studies; Dopamine Agonists; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Middle Aged; Nitrogen; Obesity; Oxygen Consumption; Prolactin; Receptors, Dopamine D2; Urea

2006
Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects.
    Diabetes care, 1996, Volume: 19, Issue:6

    Topics: Adipose Tissue; Blood Glucose; Body Mass Index; Body Weight; Bromocriptine; Diet, Reducing; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Male; Middle Aged; Obesity; Placebos; Time Factors; Weight Loss

1996
Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity.
    Journal of endocrinological investigation, 1996, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Arginine; Blood Glucose; Bromocriptine; Dopamine Agonists; Hormone Antagonists; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Middle Aged; Obesity; Prolactin; Secretory Rate

1996
Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
    Diabetes care, 1997, Volume: 20, Issue:11

    Topics: Administration, Oral; Adult; Aged; Blood Glucose; Bromocriptine; Cholesterol; Dopamine Agonists; Fasting; Fatty Acids, Nonesterified; Female; Humans; Hyperinsulinism; Insulin; Lipid Metabolism; Lipids; Lipoproteins; Middle Aged; Obesity; Postprandial Period; Prolactin; Triglycerides

1997
Bromocriptine: a novel approach to the treatment of type 2 diabetes.
    Diabetes care, 2000, Volume: 23, Issue:8

    Topics: Abdomen; Adipose Tissue; Blood Glucose; Body Mass Index; Body Weight; Bromocriptine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Hormone Antagonists; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Placebos; Time Factors; Viscera

2000
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine.
    European journal of endocrinology, 2002, Volume: 147, Issue:1

    Topics: Adolescent; Adult; Basal Metabolism; Body Weight; Bromocriptine; Dopamine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Leptin; Male; Middle Aged; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma

2002
Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Clinical endocrinology, 1975, Volume: 4, Issue:6

    Topics: Adult; Amenorrhea; Anorexia Nervosa; Bromocriptine; Clinical Trials as Topic; Contraceptives, Oral; Female; Galactorrhea; Gonadotropins; Humans; Hypophysectomy; Obesity; Ovarian Diseases; Pituitary Neoplasms; Pregnancy; Prolactin

1975
Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics.
    Experientia, 1992, Mar-15, Volume: 48, Issue:3

    Topics: Body Composition; Bromocriptine; Diabetes Mellitus, Type 2; Fats; Female; Humans; Hyperglycemia; Male; Menopause; Obesity; Skinfold Thickness

1992

Other Studies

36 other study(ies) available for bromocriptine and Obesity

ArticleYear
Dopamine D
    Psychoneuroendocrinology, 2020, Volume: 113

    Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Diabetes Mellitus, Type 2; Dopamine; Dopamine Agonists; Female; Glucose; Insulin; Insulin-Secreting Cells; Levodopa; Mice; Mice, Inbred C57BL; Obesity; Receptors, Dopamine D2; Sulpiride; Weight Gain

2020
Various and sundry recent publications.
    Journal of diabetes, 2021, Volume: 13, Issue:1

    Topics: Bromocriptine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Heart Rate; Humans; Insulin Resistance; Obesity

2021
Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.
    Molecular metabolism, 2021, Volume: 51

    Topics: Adult; Aged; Animals; Bariatric Surgery; Bromocriptine; Cohort Studies; Diabetes Mellitus, Type 2; Disease Models, Animal; Dopamine; Dopamine Agonists; Female; Humans; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Middle Aged; Obesity; Rats; Receptors, Dopamine D2

2021
Effects of running wheel training on adult obese rats programmed by maternal prolactin inhibition.
    The Journal of endocrinology, 2013, Volume: 219, Issue:1

    Topics: Animals; Bromocriptine; Female; Glycogen; L-Lactate Dehydrogenase; Lactation; Lipid Metabolism; Male; Metabolic Syndrome; Mothers; Motor Activity; Muscles; Obesity; Physical Conditioning, Animal; Prolactin; Rats; Rats, Wistar; Weaning

2013
Does bromocriptine play a role in decreasing oxidative stress for early weaned programmed obesity?
    Life sciences, 2014, Jan-24, Volume: 95, Issue:1

    Topics: Adiposity; Animals; Bromocriptine; Dyslipidemias; Female; Glucose; Injections, Intraperitoneal; Insulin Resistance; Intra-Abdominal Fat; Liver; Liver Diseases; Male; Obesity; Oxidation-Reduction; Oxidative Stress; Prolactin; Rats; Rats, Wistar; Time Factors; Weaning

2014
Bromocriptine treatment at the end of lactation prevents hyperphagia, higher visceral fat and liver triglycerides in early-weaned rats at adulthood.
    Clinical and experimental pharmacology & physiology, 2017, Volume: 44, Issue:4

    Topics: Animals; Bromocriptine; Female; Glucose; Homeostasis; Hyperphagia; Intra-Abdominal Fat; Lactation; Leptin; Liver; Male; Obesity; Rats; Rats, Wistar; Triglycerides; Weaning

2017
Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.
    Neuroendocrinology, 2009, Volume: 89, Issue:2

    Topics: Adiposity; Animals; Bromocriptine; Diet; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Eating; Hyperphagia; Male; Motor Activity; Obesity; Rats; Rats, Zucker; Receptors, Dopamine D2; Receptors, Leptin

2009
Bromocriptine reduces augmented thyrotropin secretion in obese premenopausal women.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:4

    Topics: Bromocriptine; Circadian Rhythm; Cross-Over Studies; Energy Intake; Female; Half-Life; Humans; Leptin; Obesity; Placebos; Premenopause; Pulse; Thyrotropin

2009
Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny.
    The Journal of physiology, 2009, Oct-15, Volume: 587, Issue:Pt 20

    Topics: Adult Children; Animals; Blood Glucose; Body Composition; Bromocriptine; Female; Hormone Antagonists; Humans; Lactation; Metabolic Diseases; Obesity; Prolactin; Rats; Rats, Wistar; Weaning

2009
Prolactin inhibition at mid-lactation influences adiposity and thyroid function in adult rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010, Volume: 42, Issue:8

    Topics: Adiposity; Aging; Animals; Bromocriptine; Feeding Behavior; Female; Hypothyroidism; Lactation; Leptin; Malnutrition; Milk; Obesity; Prolactin; Rats; Rats, Wistar; Thyroid Gland; Weight Gain

2010
BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
    Obesity (Silver Spring, Md.), 2011, Volume: 19, Issue:4

    Topics: Adult; Aftercare; Aged; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Bromocriptine; Cabergoline; Cholesterol, HDL; Cholesterol, LDL; Dopamine Agonists; Ergolines; Female; Humans; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metabolome; Middle Aged; Obesity; Prevalence; Prolactinoma; Waist Circumference; Weight Gain; Young Adult

2011
Obesity-resistant S5B rats showed greater cocaine conditioned place preference than the obesity-prone OM rats.
    Physiology & behavior, 2010, Dec-02, Volume: 101, Issue:5

    Topics: Analysis of Variance; Animals; Association Learning; Bromocriptine; Cocaine; Conditioning, Psychological; Dopamine Agonists; Dopamine Uptake Inhibitors; Male; Obesity; Rats; Receptors, Dopamine D2

2010
Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats.
    Behavioural brain research, 2011, Feb-02, Volume: 217, Issue:1

    Topics: Animals; Bromocriptine; Conditioning, Operant; Dietary Fats; Dose-Response Relationship, Drug; Eating; Male; Obesity; Rats; Rats, Inbred Strains; Reinforcement Schedule; Self Administration; Species Specificity

2011
Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice.
    Experimental diabetes research, 2011, Volume: 2011

    Topics: Animals; Behavior, Animal; Body Weight; Bromocriptine; Dietary Fats; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Energy Metabolism; Haloperidol; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Motor Activity; Obesity; Phenotype; Random Allocation; Receptors, Dopamine D2; Synaptic Transmission

2011
Activation of dopamine D2 receptors lowers circadian leptin concentrations in obese women.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:8

    Topics: Adult; Blood Glucose; Bromocriptine; Circadian Rhythm; Cross-Over Studies; Dopamine Agonists; Fatty Acids, Nonesterified; Female; Humans; Insulin; Leptin; Middle Aged; Norepinephrine; Obesity; Premenopause; Prospective Studies; Receptors, Dopamine D2; Receptors, Leptin; Triglycerides

2006
Bromocriptine reduces steatosis in obese rodent models.
    Journal of hepatology, 2006, Volume: 45, Issue:3

    Topics: Animals; Blood Glucose; Body Composition; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Eating; Fatty Liver; Liver; Locomotion; Male; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Zucker; Superoxide Dismutase; Triglycerides

2006
Studies in behaviour, brain and plasma biochemistry in normotensive, genetically hypertensive nonobese and/or genetically hypertensive obese rats: effect of bromocriptine.
    Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove, 1980, Volume: 23, Issue:3

    Topics: Animals; Brain; Bromocriptine; Exploratory Behavior; Female; Hypertension; Male; Obesity; Rats

1980
Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus).
    Metabolism: clinical and experimental, 1995, Volume: 44, Issue:10

    Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Cricetinae; Disease Models, Animal; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucose; Hormone Antagonists; Hyperinsulinism; Insulin; Insulin Resistance; Lipolysis; Liver; Mesocricetus; Obesity; Oxidation-Reduction; Seasons

1995
Can "resetting" hormonal rhythms treat illness?
    Science (New York, N.Y.), 1995, Sep-01, Volume: 269, Issue:5228

    Topics: Animals; Bromocriptine; Circadian Rhythm; Clinical Trials, Phase III as Topic; Darkness; Diabetes Mellitus, Type 2; Humans; Light; Melatonin; Obesity; Prolactin

1995
Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidaemia in obese and lean genetically hypertensive Koletsky rats.
    Physiological research, 1994, Volume: 43, Issue:5

    Topics: Animals; Blood Pressure; Body Weight; Bromocriptine; Disease Models, Animal; Female; Glucose Intolerance; Hyperlipidemias; Hypertension; Insulin; Lipids; Lisuride; Male; Obesity; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Sex Factors

1994
Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice.
    Life sciences, 1997, Volume: 61, Issue:10

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Body Composition; Body Weight; Bromocriptine; Dopamine Agonists; Feeding Behavior; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Dopamine D1

1997
Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters.
    Neuroendocrinology, 1998, Volume: 68, Issue:1

    Topics: Adipose Tissue; Animals; Biogenic Monoamines; Body Composition; Bromocriptine; Chromatography, High Pressure Liquid; Circadian Rhythm; Cricetinae; Dopamine; Glucose Intolerance; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus, Middle; Insulin Resistance; Male; Methoxyhydroxyphenylglycol; Microdialysis; Obesity; Serotonin

1998
Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters.
    Neuroendocrinology, 1999, Volume: 69, Issue:3

    Topics: Animals; Blood Glucose; Bromocriptine; Cricetinae; Glucose Clamp Technique; Glucose Intolerance; Injections, Intraventricular; Insulin; Insulin Resistance; Male; Mesocricetus; Obesity; Photoperiod; Weight Gain

1999
Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1999, Volume: 23, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adipose Tissue; Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus; Dopamine Agonists; Drug Synergism; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Gluconeogenesis; Lipids; Lipolysis; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Weight Loss

1999
Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: relation to the metabolic syndrome.
    International journal of molecular medicine, 2000, Volume: 5, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dopamine Agonists; Electrophysiology; Female; Glutamic Acid; Hyperglycemia; Iontophoresis; Mice; Mice, Inbred C57BL; Mice, Obese; Neurons; Norepinephrine; Obesity; Receptors, Dopamine D1; Receptors, Dopamine D2; Syndrome; Ventromedial Hypothalamic Nucleus

2000
Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster.
    Chronobiology international, 2000, Volume: 17, Issue:2

    Topics: Animals; Biogenic Monoamines; Blood Glucose; Body Weight; Bromocriptine; Circadian Rhythm; Cricetinae; Dopamine; Dopamine Agonists; Fatty Acids, Nonesterified; Glucose Intolerance; Glucose Tolerance Test; Hormones; Hypoglycemic Agents; Insulin Resistance; Male; Mesocricetus; Obesity; Serotonin; Suprachiasmatic Nucleus

2000
Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic patients.
    Diabetes care, 2000, Volume: 23, Issue:7

    Topics: Abdomen; Adipose Tissue; Blood Glucose; Bromocriptine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dopamine Agonists; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Prolactin; Skin

2000
Are the results really different?
    Diabetes care, 2000, Volume: 23, Issue:7

    Topics: Blood Glucose; Bromocriptine; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dopamine Agonists; Female; Humans; Insulin Resistance; Obesity

2000
Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male.
    Journal of endocrinological investigation, 2001, Volume: 24, Issue:6

    Topics: Biopsy; Breast Neoplasms, Male; Bromocriptine; Carcinoma, Ductal, Breast; Estradiol; Hormone Antagonists; Humans; Hypogonadism; Male; Mammography; Mastectomy; Middle Aged; Neoplasms, Multiple Primary; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Tomography, X-Ray Computed

2001
Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
    British medical journal, 1977, Jul-16, Volume: 2, Issue:6080

    Topics: Adolescent; Adult; Anorexia Nervosa; Bromocriptine; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Secretion; Obesity; Prolactin

1977
[The treatment of the climacteric syndrome in women suffering from Itsenko-Cushing disease and primary obesity].
    Likars'ka sprava, 1992, Issue:1

    Topics: Adrenal Glands; Bromocriptine; Climacteric; Combined Modality Therapy; Cushing Syndrome; Female; Humans; Hypothalamo-Hypophyseal System; Middle Aged; Norethindrone; Obesity; Ovary; Syndrome

1992
Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus.
    Metabolism: clinical and experimental, 1991, Volume: 40, Issue:6

    Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Bromocriptine; Cricetinae; Female; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Mesocricetus; Obesity; Seasons

1991
Prolactinoma in an adolescent girl: unusual response to bromocriptine therapy.
    American journal of diseases of children (1960), 1989, Volume: 143, Issue:5

    Topics: Adolescent; Bromocriptine; Female; Humans; Menstruation; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma

1989
The effect of pregnancy on the body mass index 9 months postpartum in 49 women.
    International journal of obesity, 1987, Volume: 11, Issue:6

    Topics: Aging; Body Height; Body Weight; Bromocriptine; Female; Humans; Lactation; Obesity; Postpartum Period; Pregnancy; Regression Analysis; Smoking; Time Factors

1987
Polycystic ovary syndrome.
    Comprehensive therapy, 1986, Volume: 12, Issue:12

    Topics: Androgens; Bromocriptine; Dexamethasone; Female; Genes, Dominant; Hirsutism; Humans; Hypothalamo-Hypophyseal System; Infertility, Female; Obesity; Polycystic Ovary Syndrome

1986
[Unexpected positive effect of bromocriptine on obesity and the use of psychopharmaceuticals].
    Lakartidningen, 1985, Dec-11, Volume: 82, Issue:50

    Topics: Adult; Bromocriptine; Edema; Female; Humans; Mental Disorders; Obesity; Psychotropic Drugs; Substance-Related Disorders

1985